By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Newron Pharmaceuticals 

Via R. Lepetit
21040
Gerenzano      Italy
Phone: 39-02-9668131 Fax: 39-02-96681333


SEARCH JOBS


Industry
Pharmaceutical






Company News
Newron Pharmaceuticals (NWRN) Receives Positive Opinion For Orphan Medicinal Product Designation For Sarizotan To Treat Patients With Rett Syndrome From The Committee For Orphan Medicinal Products From European Medicines Agency 6/25/2015 9:38:05 AM
Newron Pharmaceuticals (NWRN) Completes CHF24.3M/US$25.5 Million In Private Placement From Leading EU And US Investors 4/30/2015 1:26:37 PM
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/25/2015 12:57:59 PM
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/24/2015 11:25:49 AM
Newron Pharmaceuticals (NWRN) To Present At The 27th Annual ROTH Conference 3/4/2015 11:28:04 AM
Newron Pharmaceuticals (NWRN) Reports 2014 Financial Results 3/4/2015 11:25:18 AM
Newron Pharmaceuticals (NWRN) Release: Xadago (Safinamide) New Drug Application (NDA) Accepted For Filing By The FDA 3/2/2015 11:18:52 AM
Newron Pharmaceuticals (NWRN) To Present At The 17th Annual BIO CEO & Investor Conference And The Leerink Global Healthcare Conference 2/6/2015 12:00:35 PM
Newron Pharmaceuticals (NWRN) Initiates Phase 2 Study Of sNN0029 In Patients With Amyotrophic Lateral Sclerosis 1/16/2015 3:03:53 PM
Newron Pharmaceuticals (NWRN) Announces Results Of Phase I Study Of NW-3509 Phase II Study In Schizophrenia Patients Planned For Q2 2015 1/15/2015 8:55:25 AM
123456789
//-->